A breast cancer research study now open at Baylor University Medical Center in Dallas is believed to be the first of its kind to explore the ability of new weight loss GIP/GLP-1 receptor agonists to combat breast cancer recurrence in overweight or obese pa
...
Several Baylor Scott & White clinicians were recently named to Clarivate’s 2024 list of “Highly Cited Researchers” for authoring some of the most widely cited scientific publications in their fields, ranking among the top 1% of their peers.
The US Army Medical Research and Development Command, a division of the Department of Defense, awarded a $2.7 million grant to Dr. Ann Marie Warren, PhD, ABPP, principal investigator for Baylor Scott & White Research Institute, to research prevent Post-tra
...
Baylor Scott & White Health announces leadership appointments in its Central Texas region. These key leaders are advancing healthcare in communities the not-for-profit health system has served for more than 125 years.
In collaboration with Exact Sciences, Baylor Scott & White Research Institute are now enrolling its first patients in the Texas Multi-Cancer Early Detection (MCED) Registry.
Baylor University Medical Center’s uterus transplant program—the largest of its kind in the world—published the results of an eight-year trial in JAMA, finding the procedure is safe and effective, resulting in a high rate of live births. The seminal study
...
Blue Cross and Blue Shield of Texas and Baylor Scott & White Health are pleased to announce that we have agreed to extend provider and facility contracts to Oct. 1, 2024.
Baylor Scott & White The Heart Hospital – Plano1 has earned The Joint Commission's Gold Seal of Approval® and the American Heart Association's Heart-Check mark for Comprehensive Cardiac Center Certification, becoming the first hospital in Collin County and
...
The study results show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy and highlight the potential for monitoring circulating tumor DNA as a predictor for future intervention.